SteadyMed Ltd. IPO Research Information

SteadyMed Ltd. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on SteadyMed Ltd., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
SteadyMed Ltd.	STDY - NASDAQ	$12.00-$14.00	$8.50	$8.06	4.7 million	3/20/2015
Underwriter(s): Wells Fargo Securities, RBC Capital Markets
Co-Manager(s): JMP Securities
Industry: Health Care
Filing(s): Filed 2015-02-06 Terms Added 2015-03-09

SteadyMed Ltd. Quote & Chart - Click for current quote - STDY

About SteadyMed Ltd. (adapted from SteadyMed Ltd. prospectus):
They are a specialty pharmaceutical company focused on the development and commercialization of therapeutic product candidates that address the limitations of market-leading products in certain orphan and other well-defined, high-margin specialty markets.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "STDY" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.